Shanghai Medicilon DMPK/Tox Job Opening

 

Position I:  VP, Sr. Director, or Director of DMPK (Shanghai)

Description:

• Responsible for managing pharmacokinetic (PK), drug metabolism (DM) and bioanalytical (BA) services to clients worldwide.

• Provides scientific leadership for a team of scientists in the DMPK study design, data generation, analysis, and reporting.

• Responsible for overseeing and assuring compliance with SOPs, FDA and SFDA guidelines and regulations for GLP DMPK studies.


Requirements:

Education / Experience / Qualification

• PhD or PharmD is required with extensive training in pharmacokinetics, drug metabolism, and pharmacodynamics plus a minimum of 10 years of relevant postdoctoral and industry experience, especially with small molecules.

• 5-10 years of supervisory experience

• Technical knowledge of LC/MS bioanalytical methods

• Hands-on experience with PK and/or PK/PD modeling using industry standard software.

• Strong communication and interpersonal skills.

• Highly motivated and productive with a track record of being a self-starter and working well within a team.

 

Position II:  VP, Sr. Director of Toxicology (Shanghai)
Description & Requirements: (will announce later)

 

Contacts: Chunlin Chen <clchen@mediciloninc.com> (CEO);

  Mingzhu Zhang <mzzhang@mediciloninc.com> (VP and head of US BD)

Shanghai Medicilon, founded in 2004, is the pioneer in integrated drug R & D service in China that offers chemistry, discovery biology and structure biology, DMPK/PD, toxicology services to pharmaceutical and biotech companies.  With 350 employees, Medicilon occupies over 218,000 square feet of R&D facilities equipped with state-of the-art instruments in Shanghai, and is managed by a team with 10 to 20 years of working experience in US-based pharmaceutical companies.   With MPI's help and Guidance, Medicilon received AAALAC full accreditation in 2009 and is providing GLP-Tox services.  Our monkey facility, structure biology and radio-labeled in vitro & in vivo study platforms are 3 out of 18 key platforms in Zhangjiang High Tech Park in Shanghai.